These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 9659137
1. Enhancement of radiosensitivity of rat rhabdomyosarcoma R1H with normobaric carbogen and hyperbaric oxygen (HBO) using conventionally fractionated irradiation. Hartmann KA, Carl UM, Plugge DC, Schneider CJ, Sminia P. Br J Radiol; 1998 Apr; 71(844):433-7. PubMed ID: 9659137 [Abstract] [Full Text] [Related]
2. Effects of hyperbaric oxygen and normobaric carbogen on the radiation response of the rat rhabdomyosarcoma R1H. Hartmann KA, van der Kleij AJ, Carl UM, Hulshof MC, Willers R, Sminia P. Int J Radiat Oncol Biol Phys; 2001 Nov 15; 51(4):1037-44. PubMed ID: 11704328 [Abstract] [Full Text] [Related]
3. The mechanisms by which hyperbaric oxygen and carbogen improve tumour oxygenation. Brizel DM, Lin S, Johnson JL, Brooks J, Dewhirst MW, Piantadosi CA. Br J Cancer; 1995 Nov 15; 72(5):1120-4. PubMed ID: 7577456 [Abstract] [Full Text] [Related]
4. Radiosensitizing effect of carbogen breathing during pulsed irradiation of the rat R1H tumor. Sminia P, Hartmann KA, Schneider CJ, Carl UM, van der Kleij AJ, Slotman BJ, Huishof MC. Acta Oncol; 2001 Nov 15; 40(7):870-4. PubMed ID: 11859988 [Abstract] [Full Text] [Related]
5. No effect of the hemoglobin solution HBOC-201 on the response of the rat R1H tumor to fractionated irradiation. Raabe A, Gottschalk A, Hommel M, Dubben HH, Strandl T. Strahlenther Onkol; 2005 Nov 15; 181(11):730-7. PubMed ID: 16254709 [Abstract] [Full Text] [Related]
14. MRI measurements correctly predict the relative effects of tumor oxygenating agents on hypoxic fraction in rodent BA1112 tumors. Al-Hallaq HA, Zamora M, Fish BL, Farrell A, Moulder JE, Karczmar GS. Int J Radiat Oncol Biol Phys; 2000 May 01; 47(2):481-8. PubMed ID: 10802376 [Abstract] [Full Text] [Related]
15. Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen. Horsman MR, Overgaard J. Radiother Oncol; 2004 Mar 01; 70(3):301-9. PubMed ID: 15064017 [Abstract] [Full Text] [Related]
16. Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen, and nicotinamide. Hoskin PJ, Saunders MI, Dische S. Cancer; 1999 Oct 01; 86(7):1322-8. PubMed ID: 10506720 [Abstract] [Full Text] [Related]
17. Hyperbaric oxygen improves tumor radiation response significantly more than carbogen/nicotinamide. Brizel DM, Hage WD, Dodge RK, Munley MT, Piantadosi CA, Dewhirst MW. Radiat Res; 1997 Jun 01; 147(6):715-20. PubMed ID: 9189170 [Abstract] [Full Text] [Related]
18. Influence of the timing of a concomitant boost during fractionated irradiation of rat rhabdomyosarcoma R1H. Dubben HH, Beck-Bornholdt HP. Acta Oncol; 1993 Jun 01; 32(1):79-82. PubMed ID: 8466769 [Abstract] [Full Text] [Related]
19. Intermittent use of a perfluorochemical emulsion (Fluosol-DA 20%) and carbogen breathing with fractionated irradiation. Moulder JE, Fish BL. Int J Radiat Oncol Biol Phys; 1988 Nov 01; 15(5):1193-6. PubMed ID: 3141322 [Abstract] [Full Text] [Related]
20. Clinical results of hypoxic cell radiosensitisation from hyperbaric oxygen to accelerated radiotherapy, carbogen and nicotinamide. Saunders M, Dische S. Br J Cancer Suppl; 1996 Jul 01; 27():S271-8. PubMed ID: 8763896 [Abstract] [Full Text] [Related] Page: [Next] [New Search]